Boehringer Ingelheim Vetmedica Gmbh

Other

Jeremy Kroll

Michael B Roof

Eric Martin Vaughn

Philip Utley

Mike Roof

Michael Dennis Piontkowski

Volker Ohlinger

Kim Burgard

Marc Allan Eichmeyer

Merrill Lynn Schaeffer

Francois-Xavier Orveillon

Stefan Pesch

Jeffrey P Knittel

Gregory Brian Haiwick

Sarah M Layton

Troy James Kaiser

Scott Eugene Bucklin

Fuad Tawfiq Haddadin

Ali Khazraeinazmpour

Dianna Murphy Jordan

Sonia Regina Cantisano Malburg

Guosong Zhao

Stephen Scheerer

Edgar Arnulfo Sandoval Basurto

Elizabeth Jane Berry

Curtis Robert Edwards

Marta Noguera Serrat

Robert Thomas Cool

Sonja Klocke

Andrea J Headrick Starks

Michael Landon Stewart

The present invention provides combination vaccines that comprise an immunological agent effective for reducing the incidence of or lessening the severity of PPE caused by, and one or more immunological active components effective in treatment and/or prophylaxis of at least one further disease-causing organism for swine. Moreover, the present invention also relates to a kit that comprises an immunological agent effective for reducing the incidence of or lessening the severity of PPE caused by, and one or more immunological active components effective in treatment and/or prophylaxis of at least one further disease-causing organism for swine.

Immunogenic compositions comprising

The present invention relates to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.

Vaccine against porcine parvovirus

The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.

European PRRSV strain

The present invention relates to a porcine parvovirus and porcine reproductive and respiratory syndrome virus vaccine for protecting a subject, preferably swine, against diseases associated with porcine parvovirus and porcine reproductive and respiratory syndrome virus. The present invention further relates to methods of producing immunogenic compositions as well as such immunogenic compositions exhibiting reduced virucidal activity.

Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof

[object Object]

The present invention describes an efficient commercial scale production method for the preparation of PRRS virus.

Commercial scale process for production of PRRSV

The invention provides immunogenic compositions useful for inhibiting, treating, protecting, or preventing infection by. These immunogenic compositions are demonstrated to usefully stimulate immunogenic responses in treated pigs. Some vaccines stimulated reactions sufficient to be protective against. In addition, the invention provides kits comprising the immunogenic compositions; as well as, methods of using the compositions and kits.

The present invention provides a method of vaccinating a young animal againstinfection comprising the step of administering to an animal an effective dose ofantigen. It also provides a method of vaccinating an animal, preferably a young animal, having anti-antibodies or is exposed to anti-antibodies. In particular, those anti-antibodies are maternally derived antibodies.

Growing community of inventors

Urbandale, IA, United States of America

Jeremy Kroll